Brief: Hansoh Pharma And Olix Pharmaceuticals Enter Into Licensing And Collaboration Agreement
12/10/2021 12:39
Oct 12 (Reuters) - OliX Pharmaceuticals Inc 226950.KQ :
* HANSOH PHARMA AND OLIX PHARMACEUTICALS ENTER INTO
LICENSING AND
COLLABORATION AGREEMENT TO DEVELOP AND COMMERCIALIZE SIRNA
THERAPEUTICS IN GREATER CHINA
* OLIX PHARMACEUTICALS - OLIX WILL RECEIVE INITIAL UPFRONT
PAYMENT
OF $6.5 MILLION WITH UP TO $450 MILLION PLUS ROYALTIES
* OLIX PHARMACEUTICALS - HANSOH, OLIX TO FOCUS ON
CARDIOVASCULAR,
METABOLIC, AND OTHER INDICATIONS
Source text for Eikon: ID:nGNXbs0srL
Further company coverage: 226950.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OliX Pharmaceuticals
See all newsBrief: Olix Pharmaceuticals - Olx501a Shows 29.2% Visceral Fat Reduction Versus 10.0% With Comparator In Obese Non-Human Primates
Brief: Olix Pharmaceuticals Receives Milestone Payment From L'oreal
Brief: OliX And Lilly Enter Global Licensing Agreement For Mash And Other Cardiometabolic Indications
Brief: Olix Pharmaceuticals Commences Patient Dosing In Phase 1 Clinical Trial Of Olx75016
Brief: Olix Pharmaceuticals Receives Hrec Approval To Initiate Phase 1 Clinical Trial Of Nash And Obesity Drug